Stockreport

AbbVie plans to build out its presence in obesity market [Yahoo! Finance]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF treatments, leaning on the weight-loss drug it licensed ?last year from Danish biotech Gubra. Gubra's drug, GUBamy, mimics the hormone amylin and could ?be used as an [Read more]